Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Aurinia Pharmaceuticals Inc
Total Liabilities
Aurinia Pharmaceuticals Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Liabilities
$157.2m
|
CAGR 3-Years
50%
|
CAGR 5-Years
44%
|
CAGR 10-Years
34%
|
|
Zymeworks Inc
NYSE:ZYME
|
Total Liabilities
$116.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Total Liabilities
$96.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
33%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Liabilities
$41.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Liabilities
$63.4m
|
CAGR 3-Years
58%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
Spectral Medical Inc
TSX:EDT
|
Total Liabilities
CA$25m
|
CAGR 3-Years
43%
|
CAGR 5-Years
74%
|
CAGR 10-Years
23%
|
See Also
What is Aurinia Pharmaceuticals Inc's Total Liabilities?
Total Liabilities
157.2m
USD
Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Total Liabilities amounts to 157.2m USD.
What is Aurinia Pharmaceuticals Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
34%
Over the last year, the Total Liabilities growth was 156%. The average annual Total Liabilities growth rates for Aurinia Pharmaceuticals Inc have been 50% over the past three years , 44% over the past five years , and 34% over the past ten years .